Excitation functions of Ge(p,xn)As reactions from threshold up to 45 MeV for production of the non-standard positron emitter As.

Nuclear reaction cross sections for the formation of As and As in proton-induced reactions on enriched Ge targets were measured up to 45 MeV utilizing three different cyclotrons at the Forschungszentrum Jülich. The stacked-thin sample activation technique in combination with high-resolution γ-ray spectrometry was used. The major γ-ray peaks of As and As formed via the Ge(p,n)As and Ge(p,2n)As reactions, respectively, were analyzed.

Copper radionuclides for theranostic applications: towards standardisation of their nuclear data. A mini-review.

Copper has several clinically relevant radioisotopes and versatile coordination chemistry, allowing attachment of its radionuclides to biological molecules. This characteristic makes it suitable for applications in molecular imaging or radionuclide targeted therapy. Of particular interest in nuclear medicine today is the theranostic approach.

Positron Emission Intensity in the Decay of Y for Use in Dosimetry Studies.

The β-emitting radionuclide Y (t = 14.7 h) forms a matched-pair with the β-emitting therapeutic radionuclide Y (t = 2.7 d) for theranostic application in medicine.

Production cross-section measurements of proton-induced reactions on natural tantalum in the 0.3 GeV-1.7 GeV energy range.

This work reports the production cross-section data for seventy-one radionuclides produced by 0.3 GeV-1.7 GeV protons impinging on thin tantalum targets.

Production Cross-Section Measurements for Terbium Radionuclides of Medical Interest Produced in Tantalum Targets Irradiated by 0.3 to 1.7 GeV Protons and Corresponding Thick Target Yield Calculations.

This work presents the production cross-sections of Ce, Tb and Dy radionuclides produced by 300 MeV to 1.7 GeV proton-induced spallation reactions in thin tantalum targets as well as the related Thick Target production Yield (TTY) values and ratios. The motivation is to optimise the production of terbium radionuclides for medical applications and to find out at which energy the purity of the collection by mass separation would be highest.